Doctor profile · Federal record
Dr. Adam Geyer, M.D.
Dermatology Physician (CMS: Dermatology) · New York, NY
- NPI 1508804238
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 26 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
30-32 Ericsson Place
New York, NY 100136301
(212) 374-9750
fax (212) 374-9705 - Mailing address
-
505 Greenwich St, 12B
New York, NY 100131380
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- November 27, 2013
- Year of graduation
- 2000 — 26 yrs since
- Specialty taxonomy
- 207N00000X — NUCC code
- State license (1)
- New York #223986
- Medicaid
- NY #02638631
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1508804238. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
36,970
Distinct HCPCS
10
Medicare allowed
$151,051
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q2028 |
Injection, sculptra, 0.5 mg | 35,280 | 11 | $1 | |
17003 |
Destruction of precancer skin growth, 2-14 growths | 463 | 118 | $8 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 417 | 322 | $103 | |
17000 |
Destruction of precancer skin growth, 1 growth | 226 | 187 | $62 | |
17110 |
Destruction of skin growth, 1-14 growths | 140 | 113 | $130 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 110 | 97 | $145 | |
11102 |
Biopsy of related skin growth, first growth | 109 | 100 | $107 | |
17004 |
Destruction of precancer skin growth, 15 or more growths | 47 | 39 | $198 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 34 | 16 | $1 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 32 | 32 | $129 |
In context: peer comparison
Among 139 peers in New York Dermatology Physician, average services per provider: 182. This provider delivers 203× the peer median.Open Payments
Industry payments received
All-time total
$1,375
Transactions
72
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 20 | $438.69 | |
| Pfizer INC. | 23 | $262.80 | |
| Janssen Biotech, INC. | 5 | $107.48 | |
| Ucb, INC. | 3 | $76.56 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $64.58 | |
| Galderma Laboratories, L.P. | 3 | $64.17 | |
| Sun Pharmaceutical Industries INC. | 3 | $56.96 | |
| Arcutis Biotherapeutics, INC. | 2 | $48.45 | |
| Leo Pharma INC. | 2 | $47.49 | |
| Genzyme Corporation | 2 | $45.11 | |
| Incyte Corporation | 2 | $39.87 | |
| Dermavant Sciences, INC. | 1 | $26.54 | |
| Fidia Pharma USA INC. | 1 | $24.39 | |
| Lilly USA, LLC | 1 | $20.47 | |
| Amgen INC. | 1 | $20.33 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
367
Patients
201
Total drug cost
$84,787
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Triamcinolone Acetonide | Generic | 63 | 46 | $706 |
| Ciclopirox (Ciclopirox Olamine) | Brand | 55 | 37 | $1,749 |
| Minoxidil | Generic | 45 | 11 | $501 |
| Ketoconazole | Generic | 34 | 25 | $1,095 |
| Clindamycin Phosphate | Generic | 30 | 0 | $1,102 |
| Clobetasol Propionate | Generic | 29 | 19 | $1,278 |
| Metronidazole | Generic | 18 | 13 | $1,281 |
| Cefdinir | Generic | 14 | 12 | $155 |
| Fluorouracil | Generic | 14 | 14 | $1,238 |
| Mupirocin | Generic | 14 | 13 | $137 |
Frequently asked questions
What is Dr. Adam Geyer's medical specialty?
Dr. Adam Geyer practices Dermatology Physician in New York, NY.
Where does Dr. Adam Geyer practice?
Dr. Adam Geyer practices at 30-32 Ericsson Place, New York, NY 100136301. Office phone: 2123749750.
What is Dr. Adam Geyer's NPI?
Dr. Adam Geyer's National Provider Identifier (NPI) is 1508804238, issued by NPPES.
Does Dr. Adam Geyer accept Medicare assignment?
Yes. Dr. Adam Geyer accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Adam Geyer commonly perform?
Top Medicare-reported procedures in 2023: Injection, sculptra, 0.5 mg (HCPCS Q2028); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.